Liñán-Cabello Marco A, Robles-Basto Cindy M, Mena-herrera Alfredo
Acuacultura/Biotecnología, FACIMAR, Universidad de Colima, Km 19.5. Carretera Manzanillo-Barra de Navidad, Manzanillo, Colima, Mexico.
Rev Biol Trop. 2013 Mar;61(1):203-12. doi: 10.15517/rbt.v61i1.10995.
Little is known about the effects of the interaction of growth hormone (GH) with 17 alpha-methyltestosterone (17-MT) during fish growth. We evaluated this in the present study to assess the effect on fish growth. Fish in two batches of juvenile tilapia (Oreochromis niloticus) (approximately 5.0cm in length) were randomly assigned in triplicate to three treatments and a control group, distributed among 12 fiberglass tanks of 1 000L capacity (50 fish per tank) in an experiment covering a period of six weeks. The experimental groups were: a) fish treated with 17-MT and GH in mineral oil (RGH); b) fish treated with 17-MT and mineral oil without the addition of GH (R); c) fish treated with GH in mineral oil but not 17-MT (NGH); and d) fish of the control group, which were treated with mineral oil but not 17-MT or GH (N). The GH was injected into the fish at a rate of 0.625mg/g body weight. Morphometric data were recorded at the beginning of the experiment (T0) and at 15, 30 and 45 days (T15, T30 and T45), and various indicators of growth were assessed: condition factor (K); survival percentage (S), feed conversion rate (FCR), percentage weight gain (WG) and (v) daily weight gain. The optimum dietary level was calculated assuming 5% food conversion to total weight in each group. During the experiment, the fish were provided with a commercial food containing 45% protein. The data showed that GH injection resulted in a greater weight gain in fish treated with 17-MT (the RGH treatment group), being particularly significant increase in weight during T15 and T30 (p<0.05). High values of K were found in the R and RGH treatments during the initial days of the experiment, which may have been a consequence of the better nutritional status affecting both weight gain and growth in body length, as a result of the additive effects of 17-MT and GH. The fish in groups not treated with 17-MT and treated with 17-MT and added GH showed greater increases in WG per day, higher K values and lower FCRs than fish in the other groups, which suggests that greater feed efficiency occurred in the hormone-treated fish. Fish in the RGH treatment showed the most growth, suggesting a possible interaction between 17-MT and injected GH.
关于生长激素(GH)与17α-甲基睾酮(17-MT)在鱼类生长过程中相互作用的影响,目前所知甚少。在本研究中,我们对此进行了评估,以评估其对鱼类生长的影响。将两批幼罗非鱼(尼罗罗非鱼)(体长约5.0厘米)随机分成三组重复试验组和一个对照组,分配到12个容量为1000升的玻璃纤维水箱中(每个水箱50条鱼),实验为期六周。实验组分别为:a)用矿物油中的17-MT和GH处理的鱼(RGH);b)用矿物油中的17-MT处理但不添加GH的鱼(R);c)用矿物油中的GH处理但不添加17-MT的鱼(NGH);d)对照组的鱼,用矿物油处理但不添加17-MT或GH(N)。以0.625毫克/克体重的剂量给鱼注射GH。在实验开始时(T0)以及第15、30和45天(T15、T30和T45)记录形态学数据,并评估各种生长指标:肥满度(K)、存活率(S)、饲料转化率(FCR)、增重百分比(WG)和日增重(v)。假设每组食物转化率为总重量的5%,计算最佳日粮水平。在实验期间,给鱼提供含有45%蛋白质的商业饲料。数据显示,注射GH使接受17-MT处理的鱼(RGH处理组)体重增加更多,在T15和T30期间体重增加尤为显著(p<0.05)。在实验初期,R组和RGH组的K值较高,这可能是由于17-MT和GH的累加效应,使营养状况更好,从而影响了体重增加和体长生长。未接受17-MT处理以及接受17-MT并添加GH处理的组中的鱼,其每日WG增加更大,K值更高,FCR更低,这表明激素处理的鱼饲料效率更高。RGH处理组的鱼生长最为显著,表明17-MT与注射的GH之间可能存在相互作用。